Headache after Childbirth Epidural Could Indicate Subdural Hematoma
|
By HospiMedica International staff writers Posted on 29 Oct 2019 |
Women who experience headaches following neuraxial anesthesia prior to giving birth have a greater risk of developing intracranial subdural hematoma (ISH), according to a new study.
Researchers at McGill University (Montreal, Canada) and the University of Toronto (UT; Canada) reviewed the outcomes of 22,130,815 patients and deliveries in the United States between January 2010 and December 2016 in order to determine the association of post–dural puncture headache with postpartum ISH. Patients were included if they had two months of follow-up data, and did not receive a diagnostic lumbar puncture. The main outcome was ISH in the two-month postpartum period, with secondary outcomes including in-hospital mortality and occurrence of neurosurgery.
In all, there were 68,374 post–dural puncture headaches, for an overall rate of 309 per 100,000. There were 342 cases of ISH identified, indicating an incidence rate of 1.5 per 100,000 women. Of these, 100 cases were in women with post–dural puncture headache, indicating a rate of 147 hematoma cases per 100,000 deliveries in this subgroup. After adjustment for maternal age, cesarean delivery, hypertension, preeclampsia, and other co-morbidities, post–dural puncture headache had an odds ratio for subdural hematoma of 199, and an adjusted absolute risk increase of 130 per 100,000 deliveries. The study was published on September 16, 2019, in JAMA Neurology.
“When a patient has a post-dural puncture headache, they are at risk for a subdural hematoma, which can result in serious morbidity and increased mortality, and needs to be considered by any clinician looking after these patients,” said lead author Albert Moore, MD, of McGill University. “The risk is higher in patients who have coagulopathy, previous cerebral arteriovenous malformations, and hypertensive disease, and there is also a possibility that delaying a blood patch may increase the risk of developing a subdural hematoma.”
Post–dural puncture headache is thought to be caused by decreased intracranial pressure attributable to the leakage of cerebrospinal fluid (CSF) through the dural disruption, which places traction on pain-sensitive structures. Treatment often involves a blood patch, which is the injection of autologous whole blood into the epidural space. As pregnant women frequently receive neuraxial anesthesia for childbirth, they may develop symptoms of a post–dural puncture headache after their hospital discharge.
Related Links:
McGill University
University of Toronto
Researchers at McGill University (Montreal, Canada) and the University of Toronto (UT; Canada) reviewed the outcomes of 22,130,815 patients and deliveries in the United States between January 2010 and December 2016 in order to determine the association of post–dural puncture headache with postpartum ISH. Patients were included if they had two months of follow-up data, and did not receive a diagnostic lumbar puncture. The main outcome was ISH in the two-month postpartum period, with secondary outcomes including in-hospital mortality and occurrence of neurosurgery.
In all, there were 68,374 post–dural puncture headaches, for an overall rate of 309 per 100,000. There were 342 cases of ISH identified, indicating an incidence rate of 1.5 per 100,000 women. Of these, 100 cases were in women with post–dural puncture headache, indicating a rate of 147 hematoma cases per 100,000 deliveries in this subgroup. After adjustment for maternal age, cesarean delivery, hypertension, preeclampsia, and other co-morbidities, post–dural puncture headache had an odds ratio for subdural hematoma of 199, and an adjusted absolute risk increase of 130 per 100,000 deliveries. The study was published on September 16, 2019, in JAMA Neurology.
“When a patient has a post-dural puncture headache, they are at risk for a subdural hematoma, which can result in serious morbidity and increased mortality, and needs to be considered by any clinician looking after these patients,” said lead author Albert Moore, MD, of McGill University. “The risk is higher in patients who have coagulopathy, previous cerebral arteriovenous malformations, and hypertensive disease, and there is also a possibility that delaying a blood patch may increase the risk of developing a subdural hematoma.”
Post–dural puncture headache is thought to be caused by decreased intracranial pressure attributable to the leakage of cerebrospinal fluid (CSF) through the dural disruption, which places traction on pain-sensitive structures. Treatment often involves a blood patch, which is the injection of autologous whole blood into the epidural space. As pregnant women frequently receive neuraxial anesthesia for childbirth, they may develop symptoms of a post–dural puncture headache after their hospital discharge.
Related Links:
McGill University
University of Toronto
Latest Critical Care News
- Smart Wristband Technology Detects Cardiac Arrest and Alerts Responders
- AI Method Turns Toe Scan into Rapid PAD Screening Tool
- Integrated AI Pulmonary Workflow System Streamlines Detection and Follow-Up
- AI Model Predicts 10-Year Stroke Risk from Standard ECG
- Portable Ultrasound Tool Quantifies Liver Fat with MRI-Like Accuracy
- AI Tool Predicts Risk of Out-of-Hospital Cardiac Arrest
- Implantable Cytokine Device Enables Localized Immunotherapy for Ovarian Cancer
- Wearable Defibrillator Supports Quicker Beta-Blocker Optimization in Women
- High-Frequency Ultrasound Disables Viruses While Sparing Human Cells
- New Nasal Spray Enables Prehospital Neuroprotection in Ischemic Stroke
- AI-Enhanced ECG Screens for Heart Failure Risk in Resource-Limited Settings
- Single-Lead AI ECG Tool Detects Moderate-to-Severe Hyperkalemia Outside Clinic
- Reduced-Intensity Transplant Regimen Expands Donor Access in Sickle Cell Disease
- Battery-Free ECG Patch Enables Continuous Arrhythmia Monitoring
- Spinal Cord Interface Restores Bladder Control in Preclinical Study
- Rapid Clotting Gel Improves Emergency Bleeding Control
Channels
Artificial Intelligence
view channel
FDA-Cleared AI System Detects Sepsis Earlier and Reduces Mortality
Sepsis remains one of the deadliest complications for hospitalized patients, in part because its early signs overlap with other conditions. Each hour of delayed recognition measurably decreases survival,... Read moreFacial Image Analysis Tracks Biological Aging, Predicts Cancer Outcomes
Biological aging is the progressive loss of physiological function that may diverge from chronological age. In cancer care, clinicians need simple tools that reflect dynamic changes in patient resilience... Read moreSurgical Techniques
view channel
Stretchable Bioelectronic Implant Lowers Blood Pressure in Preclinical Study
Hypertension, or high blood pressure, drives major cardiovascular morbidity and affects nearly half of adults in the United States. About one in ten patients develop drug‑resistant hypertension that persists... Read more
FDA-Cleared Nerve Stimulator Advances Intraoperative Peripheral Nerve Assessment
The Evala Nerve Stimulator from Epineuron (Mississauga, ON, Canada) is a handheld, intraoperative electrical stimulation system designed to provide surgeons with a rapid and accurate method for nerve identification... Read morePatient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read moreHealth IT
view channel
EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read more
AI System Detects and Quantifies Chronic Subdural Hematoma
Viz.ai (San Francisco, CA, USA) announced a strategic commercialization collaboration with Johnson & Johnson (New Brunswick, NJ, USA) to expand access in the United States to the Viz Subdural solution... Read more
Continuous Monitoring Platform Detects Infection Risk Across Care Transitions
Patients leaving skilled nursing facilities often lose continuous physiologic monitoring, increasing the risk of undetected infection and delayed intervention. Nursing home residents are seven times more... Read more
Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings
Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read morePoint of Care
view channel
Point-of-Care Viscoelastic Testing System Supports Obstetric Bleeding Management
HemoSonics (Durham, NC, USA) announced on May 5, 2026 that the company's Quantra Hemostasis System for Obstetric Procedures won Silver in the 2026 Edison Awards in the Women’s Health and Reproductive Innovations... Read moreBusiness
view channel
Olympus Partnership Aims to Expand Access to Robot-Assisted Endoscopic Therapy
Olympus has signed an exclusive global distribution agreement with EndoRobotics Co., Ltd., under which robot-assisted technologies developed by EndoRobotics will be distributed worldwide as part of the... Read more







